Ceresity Technologies appointed Mehul Mehta as Board Advisor.

Ceresity is a metadata governance layer purpose-built for modern clinical trials. We enable sponsors, CROs, and clinical teams to design, execute, and deliver trials with complete data traceability, lineage, and regulatory readiness from protocol design through submission. Clinical trials today generate data across multiple systems EDC, ePRO, labs, imaging, and more. Yet the metadata connecting these systems remains fragmented, leading to inconsistencies, rework, and delayed submissions. Ceresity addresses this gap by introducing a structured governance layer that connects protocol design, data flow, and regulatory outputs into a unified, traceable system. Our platform ensures: • End-to-end metadata governance • Transparent data lineage across trial lifecycle • Early-stage protocol intelligence and risk identification • Automated quality control for clinical documents and datasets • Submission-ready data aligned with global regulatory standards By embedding governance at the core, we help reduce protocol amendments, accelerate trial timelines, and improve data integrity across complex clinical programs. Ceresity is not another tool. It is the infrastructure layer that modern clinical trials have been missing.